Four Must-Have Capabilities for Modern eCOA/ePRO
Modern trials require modern solutions. Here are four must-have capabilities for your eCOA/ePRO solution.
Modern trials require modern solutions. Here are four must-have capabilities for your eCOA/ePRO solution.
Goasduff (2021) reported that the global usage of electronic devices was approximately 6.2 billion in 2021, and experts predict that it will reach 6.4 billion in 2022. Like other industries, healthcare is undergoing a transition from traditional paper formats to digital tools. This transition ranges from physical devices, such as computers, tablets, and mobile phones, …
Don’t settle for delayed reports, you need real-time data to react quickly and effectively to the needs of your clinical trial. eCOA data reporting shouldn’t be complicated, simplify the complex with Datacubed Health.
Read moreWhy eCOA data reporting often falls short (and what to do about it)
By infusing behavioral science principles into our technology, we’re able to better engage and retain participants in studies for the long-term. Learn more.
Read moreEyes on the prize: Datacubed releases new Treasure Chest Store
Discover how combining behavioral science with innovative technology can improve patient engagement and the success of a CNS study.
Read moreFour Ways to Improve Patient Engagement and Strengthen Data Collection in CNS Trials
VIRTUAL STUDY YIELDS HIGH COMPLIANCE & RETENTION RATES BACKGROUND Clinical research studies involving repeated patient-reported outcome measures (PROs) face several challenges. Patients may fail to complete individual PROs, whether at all or within a specified time (i.e., reduced compliance). Patients may cease participating in a study altogether, dropping out before all study procedures are completed …
ENSURING LONG-TERM PATIENT ENGAGEMENT IN AN ONCOLOGY TRIAL WITH CLINICAL MANAGEMENT SOLUTIONS Breast cancer is the most prevalent cancer and most frequent cause of cancer-related death and can be classified depending on hormone receptor expression.1 Hormone receptor expression ultimately influences the course of treatment and prognosis. ER-positive breast cancers are associated with the overexpression of …
Successful retention and compliance of patients in clinical trials are significant challenges in the arduous path to drug approval1,2. Missing outcome data caused by patient dropout and poor compliance not only jeopardize the scientific validity of a study but also comes at a high financial cost to study sponsors. Technology and behavioral science offer potential …
Use of geofencing software on the Linkt case management platform constitutes an innovative solution for detecting adverse events and outcomes for large-scale, long-duration clinical trials and research. Geofencing uses location information securely held within a participant’s own device (e.g., mobile phone) to allow the device to detect whether a participant has crossed a virtual perimeter …
Studies show that electronic patient reporting yields higher-quality data than paper-based diaries. As a matter of fact, electronic patient-reported outcomes (ePROs) drive greater participant compliance. With our behavioral science-driven platform, compliance rates are consistently above 90%, and retention rates are above 85% in our client’s clinical trials. For the past decade, both the FDA and …